The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor-derived GDF-15 to suppress t-lymphocyte recruitment to the tumor microenvironment resulting in resistance to ANTI-PD-1 treatment.
 
Joerg Wischhusen
Leadership - Catalym
Stock and Other Ownership Interests - Catalym
Consulting or Advisory Role - Catalym
Research Funding - Aeterna Zentaris (Inst); Catalym (Inst)
Patents, Royalties, Other Intellectual Property - Catalym (Inst)
 
Markus Haake
Employment - Catalym
Stock and Other Ownership Interests - Catalym
Patents, Royalties, Other Intellectual Property - Universtity of Wuerzburg
 
Neha Vashist
Employment - Catalym
 
Sabrina Genßler
Employment - Catalym
 
Kilian Wistuba-Hamprecht
Research Funding - Catalym (Inst)
 
Patrick Harter
No Relationships to Disclose
 
Alexander Martens
Employment - Becton Dickinson
 
Michel Mittelbronn
No Relationships to Disclose
 
Mitchell P. Levesque
Stock and Other Ownership Interests - Oncobit
Research Funding - Molecular Partners; Novartis; Roche
Patents, Royalties, Other Intellectual Property - Oncobit
 
Reinhard Dummer
Honoraria - Alligator Bioscience; Amgen; Bristol-Myers Squibb; Catalym; MaxiVax; MSD; Novartis; Pierre Fabre; Regeneron; Roche; Sanofi; Second Genome; Sun Pharma; Takeda; touchIME
Consulting or Advisory Role - Alligator Bioscience; Amgen; Bristol-Myers Squibb; Catalym; MaxiVax; MSD; Novartis; Pierre Fabre; Regeneron; Roche; Sanofi; Second Genome; Sun Pharma; Takeda; touchIME
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
 
Benjamin Weide
No Relationships to Disclose
 
Marij JP Welters
No Relationships to Disclose
 
Sjoerd H van der Burg
Consulting or Advisory Role - Aglaia BioMedical Ventures; CHDR Innovation Services; DCPrime; ISA Pharmaceuticals; PCI Biotech
Research Funding - Frame Therapeutics (Inst); IO Biotech (Inst)
Patents, Royalties, Other Intellectual Property - ISA Pharmaceuticals (Inst); Pamgene (Inst)
 
Manfred Ruediger
Employment - Catalym
Leadership - 4SC; Catalym
Stock and Other Ownership Interests - 4SC; Catalym
 
Eugen Leo
Employment - Catalym; T-Knife
Leadership - Catalym; T-Knife
Stock and Other Ownership Interests - Catalym; T-Knife
 
Falk Nimmerjahn
Research Funding - Catalym (Inst)
 
Christine Schuberth-Wagner
Employment - Catalym
Leadership - Catalym
Stock and Other Ownership Interests - Catalym
Honoraria - Lodo Therapeutics
Consulting or Advisory Role - Lodo Therapeutics
Patents, Royalties, Other Intellectual Property - MSD; University of Bonn